Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896925990> ?p ?o ?g. }
- W2896925990 endingPage "2559" @default.
- W2896925990 startingPage "2552" @default.
- W2896925990 abstract "OBJECTIVE This study evaluated the long-term safety and efficacy of dapagliflozin as an adjunct to adjustable insulin in patients with type 1 diabetes and inadequate glycemic control. RESEARCH DESIGN AND METHODS DEPICT-1 (Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes) was a randomized (1:1:1), double-blind, placebo-controlled phase 3 study of dapagliflozin 5 mg and 10 mg in patients with type 1 diabetes (HbA1c 7.5–10.5% [58–91 mmol/mol]) (NCT02268214). The results of the 52-week study, consisting of the 24-week short-term and 28-week extension period, are reported here. RESULTS Of the 833 patients randomized into the study, 708 (85%) completed the 52-week study. Over 52 weeks, dapagliflozin 5 mg and 10 mg led to clinically significant reductions in HbA1c (difference vs. placebo [95% CI] −0.33% [−0.49, −0.17] [−3.6 mmol/mol (−5.4, −1.9)] and −0.36% [−0.53, −0.20] [−3.9 mmol/mol (−5.8, −2.2)], respectively) and body weight (difference vs. placebo [95% CI] −2.95% [−3.83, −2.06] and −4.54% [−5.40, −3.66], respectively). Serious adverse events were reported in 13.4%, 13.5%, and 11.5% of patients in the dapagliflozin 5 mg, 10 mg, and placebo groups, respectively. Although hypoglycemia events were comparable across treatment groups, more patients in the dapagliflozin groups had events adjudicated as definite diabetic ketoacidosis (DKA; 4.0%, 3.4%, and 1.9% in dapagliflozin 5 mg, 10 mg, and placebo groups, respectively). CONCLUSIONS Over 52 weeks, dapagliflozin led to improvements in glycemic control and weight loss in patients with type 1 diabetes, while increasing the risk of DKA." @default.
- W2896925990 created "2018-10-26" @default.
- W2896925990 creator A5003323204 @default.
- W2896925990 creator A5004521406 @default.
- W2896925990 creator A5004966069 @default.
- W2896925990 creator A5005405894 @default.
- W2896925990 creator A5005612876 @default.
- W2896925990 creator A5006184249 @default.
- W2896925990 creator A5006226070 @default.
- W2896925990 creator A5006516877 @default.
- W2896925990 creator A5006947224 @default.
- W2896925990 creator A5007333141 @default.
- W2896925990 creator A5009102492 @default.
- W2896925990 creator A5009167703 @default.
- W2896925990 creator A5009315825 @default.
- W2896925990 creator A5009630830 @default.
- W2896925990 creator A5010827344 @default.
- W2896925990 creator A5011320591 @default.
- W2896925990 creator A5011421258 @default.
- W2896925990 creator A5012218356 @default.
- W2896925990 creator A5012551917 @default.
- W2896925990 creator A5013021433 @default.
- W2896925990 creator A5013896916 @default.
- W2896925990 creator A5014044418 @default.
- W2896925990 creator A5014865410 @default.
- W2896925990 creator A5015133665 @default.
- W2896925990 creator A5016468901 @default.
- W2896925990 creator A5016656278 @default.
- W2896925990 creator A5017307659 @default.
- W2896925990 creator A5017367769 @default.
- W2896925990 creator A5017671765 @default.
- W2896925990 creator A5017707438 @default.
- W2896925990 creator A5017811192 @default.
- W2896925990 creator A5019852974 @default.
- W2896925990 creator A5020174004 @default.
- W2896925990 creator A5020593050 @default.
- W2896925990 creator A5021232038 @default.
- W2896925990 creator A5022015994 @default.
- W2896925990 creator A5023215107 @default.
- W2896925990 creator A5024340160 @default.
- W2896925990 creator A5025302349 @default.
- W2896925990 creator A5025732053 @default.
- W2896925990 creator A5025995712 @default.
- W2896925990 creator A5026806919 @default.
- W2896925990 creator A5026948710 @default.
- W2896925990 creator A5027098809 @default.
- W2896925990 creator A5027624056 @default.
- W2896925990 creator A5028301400 @default.
- W2896925990 creator A5028970555 @default.
- W2896925990 creator A5029568219 @default.
- W2896925990 creator A5030205518 @default.
- W2896925990 creator A5031210930 @default.
- W2896925990 creator A5032167073 @default.
- W2896925990 creator A5032171473 @default.
- W2896925990 creator A5032297044 @default.
- W2896925990 creator A5032877471 @default.
- W2896925990 creator A5033602578 @default.
- W2896925990 creator A5034096266 @default.
- W2896925990 creator A5034730806 @default.
- W2896925990 creator A5034967151 @default.
- W2896925990 creator A5035111372 @default.
- W2896925990 creator A5035682991 @default.
- W2896925990 creator A5036207036 @default.
- W2896925990 creator A5036369174 @default.
- W2896925990 creator A5036581436 @default.
- W2896925990 creator A5036739670 @default.
- W2896925990 creator A5036886997 @default.
- W2896925990 creator A5037356840 @default.
- W2896925990 creator A5037652425 @default.
- W2896925990 creator A5037807737 @default.
- W2896925990 creator A5037824940 @default.
- W2896925990 creator A5038500766 @default.
- W2896925990 creator A5038863436 @default.
- W2896925990 creator A5038874937 @default.
- W2896925990 creator A5038972562 @default.
- W2896925990 creator A5039339457 @default.
- W2896925990 creator A5039563874 @default.
- W2896925990 creator A5040054137 @default.
- W2896925990 creator A5040311049 @default.
- W2896925990 creator A5041694751 @default.
- W2896925990 creator A5041935551 @default.
- W2896925990 creator A5042407874 @default.
- W2896925990 creator A5043614871 @default.
- W2896925990 creator A5044288681 @default.
- W2896925990 creator A5045489578 @default.
- W2896925990 creator A5045882994 @default.
- W2896925990 creator A5046196398 @default.
- W2896925990 creator A5046547626 @default.
- W2896925990 creator A5047160563 @default.
- W2896925990 creator A5047211412 @default.
- W2896925990 creator A5047549223 @default.
- W2896925990 creator A5047640248 @default.
- W2896925990 creator A5048231993 @default.
- W2896925990 creator A5048670308 @default.
- W2896925990 creator A5049221599 @default.
- W2896925990 creator A5049482554 @default.
- W2896925990 creator A5049534125 @default.
- W2896925990 creator A5049595236 @default.